CLINICAL_TRIALS
trial_result
· 2025-12-04
Clinical Trial Update: Ixazomib Maintenance Study in Patients With AL Amyloidosis [Phase 2]
Summary
A Phase 2 study evaluating ixazomib as maintenance therapy for AL amyloidosis, with the trial currently active and not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: AL Amyloidosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING